Disclosures:
Disclosure of Conflicts of Interest:
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.
| Beth Faiman PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO |
Beth Faiman has disclosed that she received consulting fees from BMS, GSK, J&J, Karyopharm Therapeutics, Pfizer, and Sanofi. |
| Donna D. Catamero ANP-BC, OCN®, CCRC |
Donna Catamero has disclosed that she received speaking honoraria from BMS and J&J, and consulting fees from BMS, J&J, and Legend Biotech. |
| Tiffany Richards Phd, ANP-BC-AOCNP® |
Tiffany Richards has disclosed that she received consulting fees from BMS, J&J, Pfizer, and Sanofi. |
| Mary Steinbach DNP-APRN |
Mary Steinbach has disclosed that she received speaking honoraria from BMS, J&J, and Pfizer, and consulting fees from J&J and Pfizer. |
The staff reported the following relevant financial relationships they have with ineligible companies related to the content of this activity:
| Diane Moran RN, MA, EdM |
Diane Moran has no relevant financial relationships to report. |
| Michelle Faber MS |
Michelle Faber has no relevant financial relationships to report. |
| Joyce Divine PhD, MBA |
Joyce Divine has no relevant financial relationships to report. |
All of the relevant financial relationships listed for these individuals have been mitigated.
The PIM planners and others have nothing to disclose.
Off-label use of drugs may be discussed.